AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 86 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.18 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $70,000 | – | 25,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,866,483 | $4,285,000 | 2.24% |
| Sarissa Capital Management LP | 2,570,759 | $3,843,000 | 1.32% |
| Greylock XI GP Limited Partnership | 584,004 | $876,000 | 0.56% |
| Deer VI & Co. LLC | 675,242 | $1,013,000 | 0.44% |
| DAFNA Capital Management LLC | 261,507 | $391,000 | 0.34% |
| Palo Alto Investors LP | 2,858,348 | $4,274,000 | 0.18% |
| Baupost Group | 3,829,350 | $5,725,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 573,416 | $857,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,011,000 | 0.03% |
| TFS CAPITAL LLC | 176,633 | $264,000 | 0.02% |